Dermatology
- Acne Vulgaris
- Actinic Keratosis
- Aesthetic Dermal Filler
- Alopecia
- Atopic Dermatitis
- Basal Cell Carcinoma
- Cellulite
- Dercum’s Disease
- Genital Warts
- Healthy Volunteers
- Head Lice
- Herpetic Injections
- Keloid Scar
- Melasma
- Onychomycosis
- Photodamage, including Lentigines
- Psoriasis
- Plaque Psoriasis
- Rosacea
- Scalp Psoriasis
- SunScreen
- Venous Leg & Diabetic Foot Ulcers
- Tinea Pedis & Corporis
Integrium’s Dermatology Clinical Trial Experience
* Over 100 dermatologic studies completed
* 45 Phase I HPA, irritation & sensitization, bioavailability, QTc, and safety studies for topical, systemic, and aesthetic therapies
Largest Trial by Indication – 150+ Trials | ||||
---|---|---|---|---|
Study Phase | Indication | # Patients | # Sites | Location |
III | Diabetic Foot Ulcer | 1,000 | 91 | N. America |
III | Diabetic Foot Ulcer | 400 | 37 | N. America |
II | Papulopastular Rosacea | 240 | 15 | N. America |
I, III | Actinic Keratosis | 240 | 20 | N. America |
IIb | Venous Leg Ulcer | 120 | 8 | N. America and S. Africa |
I – IV | Acne Vulgaris | 160 | 5 | N. America |
I | Plaque Psoriasis | 34 | 1 | N. America, Europe |
III – IV | Scalp Psoriasis | 30 | 1 | N. America |
III | Aesthetic Dermal Filler | 30 | 1 | N. America |
III | Alopecia | 30 | 1 | N. America |
IB – IV | Atopic Dermatitis | 30 | 1 | N. America, Australia, Europe, S. Africa |
III | Basal Cell Carcinoma | 30 | 1 | N. America |
III | Genital Warts | 30 | 1 | N. America |
III | Head Lice | 30 | 1 | N. America |
III | Herpetic Infections | 30 | 1 | N. America |
III | Melasma | 30 | 1 | N. America |
II – IV | Onychomycosis | 30 | 1 | N. America, Europe |
III | Photodamage, including lentigines | 30 | 1 | N. America |
I – III | Sun Screen | 30 | 1 | N. America |
III | Tinea Pedis & Corporis | 30 | 1 | N. America |